These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4597989)

  • 21. Chloramphenicol 1. Hazards of use and the current regulatory environment.
    Page SW
    Aust Vet J; 1991 Jan; 68(1):1-2. PubMed ID: 2018448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aplastic anemia following chloramphenicol treatment].
    Armata J; Wyszkowski J; Zajaczkowski J; Cyklis R
    Pol Tyg Lek; 1971 Apr; 26(15):557-9. PubMed ID: 5578684
    [No Abstract]   [Full Text] [Related]  

  • 23. Ocular chloramphenicol and aplastic anemia.
    Fraunfelder FT; Bagby GC
    N Engl J Med; 1983 Jun; 308(25):1536. PubMed ID: 6855828
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced aplastic anaemia in Sweden with special reference to chloramphenicol.
    Böttiger LE
    Postgrad Med J; 1974 Oct; 50 Suppl 5():127-31. PubMed ID: 4470806
    [No Abstract]   [Full Text] [Related]  

  • 25. Aplastic anaemia following chloramphenicol therapy in Hamburg and surrounding districts.
    Hausmann K; Skrandies G
    Postgrad Med J; 1974 Oct; 50 Suppl 5(581):131-6. PubMed ID: 4470808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The current status of chloramphenicol.
    Meissner HC; Smith AL
    Pediatrics; 1979 Sep; 64(3):348-56. PubMed ID: 384354
    [No Abstract]   [Full Text] [Related]  

  • 27. Marrow aplasia following topical application of chloramphenicol eye ointment.
    Abrams SM; Degnan TJ; Vinciguerra V
    Arch Intern Med; 1980 Apr; 140(4):576-7. PubMed ID: 7362398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of chloramphenicol eyedrops.
    Firkin F; Campbell T
    Aust N Z J Ophthalmol; 1997 Feb; 25(1):3. PubMed ID: 9107388
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chloramphenicol therapy].
    Blut; 1970 Feb; 20(2):125-6. PubMed ID: 5467350
    [No Abstract]   [Full Text] [Related]  

  • 30. Aplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature.
    Issaragrisil S; Piankijagum A
    J Med Assoc Thai; 1985 Jun; 68(6):309-12. PubMed ID: 4056637
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical chloramphenicol for eye infections.
    Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS
    Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chloramphenicol in ophthalmic instillation and risk of generalized sensitization].
    Verin P; Sekkat A; Morax S
    Bull Soc Ophtalmol Fr; 1972 Mar; 72(3):365-70. PubMed ID: 4643424
    [No Abstract]   [Full Text] [Related]  

  • 33. [Systemic side effects due to external application of chloramphenicol].
    Hautarzt; 1985 Mar; 36(3):181-3. PubMed ID: 3997517
    [No Abstract]   [Full Text] [Related]  

  • 34. Surveillance of drug induced diseases in children.
    Kushwaha KP; Verma RB; Singh YD; Rathi AK
    Indian J Pediatr; 1994; 61(4):357-65. PubMed ID: 8002064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Drug Reactions Advisory Committee (ADRAC) Report for 1975.
    Med J Aust; 1977 Apr; 1(14):499-501. PubMed ID: 17052
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chloramphenicol and its place in the series of our therapeutic possibilities].
    Uhlír O; Jirícková J
    Vnitr Lek; 1978 Sep; 24(9):884-92. PubMed ID: 695356
    [No Abstract]   [Full Text] [Related]  

  • 37. Hematologic side-effects of chloramphenicol.
    Schröter W
    Neuropadiatrie; 1974 May; 5(2):117-20. PubMed ID: 4601885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Four additional cases of aplastic anemia following chloramphenicol therapy].
    Speck B; Moeschlin S
    Schweiz Med Wochenschr; 1969 Jun; 99(25):910-4. PubMed ID: 4241791
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incidence and prevalence of adverse drug reactions].
    Haramburu F; Pouyanne P; Imbs JL; Blayac JP; Bégaud B
    Presse Med; 2000 Jan; 29(2):111-4. PubMed ID: 10682042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom].
    D'Arcy PF
    J Pharm Belg; 1999; 54(2):44-7. PubMed ID: 10380410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.